Georgia’s Court of Appeals will hear oral arguments in March that could settle the issuing of up to $28 million in stock to Blue Cross and Blue Shield of Georgia policyholders.

The money constitutes shares of Cerulean Inc., the parent company of the Georgia Blues. The stock was offered to all 144,000 policyholders of the Georgia companies, but only about half had accepted the offer of five shares each when the distribution was closed.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]